Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study.

× No keyword cloud information.

6 in total

1. Dexamethasone intravitreal implant in retinal vein occlusion:real-life data from a prospective, multicenter clinical trial.

Authors: Dan Călugăru; Mihai Călugăru
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2016-11-30 Impact factor: 3.117

2. Comment on: 'Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab'.

Authors: D Călugăru; M Călugăru
Journal: Eye (Lond) Date: 2016-02-12 Impact factor: 3.775

3. Comment on "Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion".

Authors: Dan Călugăru; Mihai Călugăru
Journal: Int J Ophthalmol Date: 2017-09-18 Impact factor: 1.779

Review 4. Bevacizumab in the treatment of acute central/hemicentral retinal vein occlusions.

Authors: Dan Călugăru; Mihai Călugăru; Ștefan Țălu
Journal: Rom J Ophthalmol Date: 2016 Jul-Sep

5. Intravitreal ziv-aflibercept for recurrent macular edema secondary to central retinal venous occlusion.

Authors: Jay Chhablani
Journal: Indian J Ophthalmol Date: 2015-05 Impact factor: 1.848

6. High Density Display of an Anti-Angiogenic Peptide on Micelle Surfaces Enhances Their Inhibition of αvβ3 Integrin-Mediated Neovascularization In Vitro.

Authors: Rajini Nagaraj; Trevor Stack; Sijia Yi; Benjamin Mathew; Kenneth R Shull; Evan A Scott; Mathew T Mathew; Divya Rani Bijukumar
Journal: Nanomaterials (Basel) Date: 2020-03-22 Impact factor: 5.076

6 in total